Innate Pharma S.A. (EPA:IPH)
1.900
-0.016 (-0.84%)
Jun 6, 2025, 1:27 PM CET
Innate Pharma Revenue
In the year 2024, Innate Pharma had annual revenue of 20.12M EUR, down -67.36%. Innate Pharma had revenue of 7.78M in the half year ending December 31, 2024, a decrease of -35.66%.
Revenue
20.12M
Revenue Growth
-67.36%
P/S Ratio
8.78
Revenue / Employee
111.17K
Employees
181
Market Cap
176.57M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.12M | -41.52M | -67.36% |
Dec 31, 2023 | 61.64M | 3.97M | 6.88% |
Dec 31, 2022 | 57.67M | 32.97M | 133.47% |
Dec 31, 2021 | 24.70M | -45.07M | -64.60% |
Dec 31, 2020 | 69.77M | -15.68M | -18.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 26.51B |
Sanofi | 45.17B |
Sartorius Stedim Biotech | 2.86B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.64B |
Innate Pharma News
- 11 days ago - Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences - Business Wire
- 15 days ago - Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides - Business Wire
- 15 days ago - Outcome of Innate Pharma's 2025 Annual General Meeting - Business Wire
- 19 days ago - Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting - Business Wire
- 23 days ago - Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress - Business Wire
- 24 days ago - Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Innate Pharma S.A. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 24 days ago - Innate Pharma S.A. reports Q1 results - Seeking Alpha